Cargando…
2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines
The recent American Society of Hematology/ISTH/National Hemophilia Foundation/World Federation of Hemophilia 2021 guidelines on the diagnosis of von Willebrand disease (VWD) is an outstanding effort to unify the diagnosis of VWD. However, as mentioned in the guidelines, there are limitations due to...
Autores principales: | Othman, Maha, Favaloro, Emmanuel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689114/ https://www.ncbi.nlm.nih.gov/pubmed/34977447 http://dx.doi.org/10.1002/rth2.12635 |
Ejemplares similares
-
Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources
por: Favaloro, Emmanuel J., et al.
Publicado: (2023) -
Comparison of 2 ways of performing ristocetin-induced platelet agglutination mixing study for diagnosis of type 2B von Willebrand disease. Response to the publication of Soleimani et al
por: Favaloro, Emmanuel J., et al.
Publicado: (2023) -
Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020) -
Comparing the quality of testing for von Willebrand disease in different geographic localities
por: Favaloro, Emmanuel J.
Publicado: (2022) -
Letter in response to Colpani et al “A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”
por: Favaloro, Emmanuel J.
Publicado: (2023)